We are live on
!
Find out more
ST
Skorpios Trust Portfolio holdings
AUM
$53.2M
1-Year Est. Return
90.96%
This Fund
S&P 500
This Quarter
Est. Return
-5.65%
1 Year Est. Return
+90.96%
3 Year Est. Return
+173.58%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$452M
AUM Growth
–
Cap. Flow
+$455M
Cap. Flow
% of AUM
100.73%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Stoke Therapeutics
STOK
|
+$345M |
| 2 |
AKRO
Akero Therapeutics
AKRO
|
+$109M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$1.48M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$203K |
| 5 |
Organon & Co
OGN
|
+$17.3K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 99.64% |
| 2 | Technology | 0.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Stoke Therapeutics
STOK
$1.83B
| $347M | 76.67% |
+14,443,681
| New | +$345M |
|
|
AKRO
2
DELISTED
Akero Therapeutics
AKRO
| $104M | 22.97% |
+4,907,829
| New | +$109M |
|
|
ATVI
3
DELISTED
Activision Blizzard
ATVI
| $1.44M | 0.32% |
+21,600
| New | +$1.48M |
|
|
4
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| $189K | 0.04% |
+1,686
| New | +$203K |
|
|
5
Organon & Co
OGN
$3.55B
| $16K | ﹤0.01% |
+530
| New | +$17.3K |
|
Similar funds
ACM
QUSVM
CCCPV
SGA
NCFG
E
RPM
ECT